REGENCELL BIOSCIENCE HOLDINGS LIMITED
RGCLoading price...
Overview
Previous Close609.10
Open660.00
Ask0.00
Bid0.00
Day's Range620.00 - 691.00
52 Week Range3.03 - 950.00
PE Ratio(TTM)--
Market Cap8.26B
Volume21.06k
Avg. Volume699.75k
12 Months Earnings-4.30M
12 Months Revenue0.00
Profit/Loss
| PARTICULARS | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.74M | 4.74M | 6.27M | 7.62M | 1.38M |
| Profit after Tax (Net Income) | -4.30M | -4.30M | -5.87M | -7.45M | -1.35M |
Company Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Causeway Bay, Hong Kong
Website: https://www.regencellbioscience.com
Founder, Chairman & CEO: Mr. Yat-Gai Au
Employees: 12
About Company:
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.